Table 1.
Final diagnoses, patient characteristics, needle type used, and cases in which TBNA was the only technique that permitted the diagnosis.
| Pathology | Patients, n (%) | Age# in years | Male, n (%) | Cytology needle, n (%) | Unique diagnostic, n (%) |
|---|---|---|---|---|---|
| Non-small cell lung carcinoma¶ | 280 (48.3%) | 62.0 (42-87) | 221 (79.5%) | 262 (93.6%) | 96 (34.2%) |
| Small cell lung carcinoma | 74 (12.8%) | 65.0 (34-89) | 62 (83.8%) | 62 (83.8%) | 30 (40.5%) |
| Extrapulmonary carcinoma+ | 44 (7.6%) | 61.5 (26-81) | 21 (47.7%) | 34 (77.3%) | 16 (36.3%) |
| Sarcoidosis | 57 (9.8%) | 39.5. (21-75) | 29 (58.9%) | 4 (7.0%) | 20 (35.1%) |
| Tuberculosis | 19 (3.3%) | 58.0 (38-79) | 11 (57.9%) | 3 (15.8%) | 8 (42.1%) |
| Lymphoma | 15 (2.6%) | 66.0 (29-81) | 7 (46.7%) | 3 (20.0%) | 4 (26.7%) |
| Anthracotic and reactive | 91 (15.7%) | 63.0 (21-85) | 71 (78.0%) | 46 (50.5%) | 11 (12.1%) |
| Total | 580 | 62.0 (21-89) | 422 (72.8%) | 414 (71.4%) | 214 (31.8%) |
#Data are presented as median (range).
¶130 adenocarcinomas, 83 large-cell undifferentiated carcinomas, 67 squamous cell carcinomas.
+13 breast, 10 renal, 5 larynx, 4 colon, 3 gastric, 2 hepatocarcinoma, 2 prostate, 1 endometrium, 1 ovary, 1 bladder, 1 thymus, 1 esophagus.